Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network

Medha Darshan, Qizhi Zheng, Helen L. Fedor, Nicolas Wyhs, S Yegnasubramanian, Peng Lee, Jonathan Melamed, George J. Netto, Bruce Trock, Angelo Michael Demarzo, Karen Sfanos

Research output: Contribution to journalArticle

Abstract

BACKGROUND The goal of the Prostate Cancer Biorepository Network (PCBN) is to develop a biorepository with high-quality, well-annotated specimens obtained in a systematic, reproducible fashion using optimized and standardized protocols, and an infrastructure to facilitate the growth of the resource and its wide usage by the prostate cancer research community. An emerging area of concern in the field of prostate cancer biobanking is an apparent shift in the proportion of surgical procedures performed for prostate cancer treatment from radical retropubic prostatectomy (RRP) to robot-assisted laparoscopic prostatectomy (RALP). Our study aimed to determine the potential impact of the RALP procedure on the detection of known prostate cancer biomarkers, and the subsequent suitability of RALP-derived specimens for prostate cancer biomarker studies. METHODS DNA and RNA were extracted from RRP and RALP specimens. Quality assessment was conducted using spectrophotometric analysis and RNA was analyzed for RNA integrity number (RIN) and by real-time reverse-transcription PCR (qRT-PCR) for racemase, hepsin, ERG, TMPRSS2-ERG gene fusions, and the microRNAs miR-26a, miR-26b, miR-141, and miR-221. RESULTS We demonstrate that extraction of derivatives from frozen tissues from RRP and RALP specimens yields samples of equally high quality as assessed by spectrophotometric and RIN analysis. Likewise, expression levels of genes analyzed by qRT-PCR did not differ between RRP and RALP-derived tissues. CONCLUSIONS Our studies indicate that samples obtained from RALP specimens may be suitable for prostate cancer biomarker studies - an important finding given the current shift in surgical procedures for prostate cancer treatment.

Original languageEnglish (US)
Pages (from-to)61-69
Number of pages9
JournalProstate
Volume74
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Prostatectomy
Prostatic Neoplasms
Tumor Biomarkers
RNA
Polymerase Chain Reaction
Racemases and Epimerases
Gene Fusion
MicroRNAs
Reverse Transcription
Gene Expression

Keywords

  • biobanking
  • biomarker
  • biorepository
  • DNA
  • prostate cancer
  • RNA

ASJC Scopus subject areas

  • Urology
  • Oncology

Cite this

Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network. / Darshan, Medha; Zheng, Qizhi; Fedor, Helen L.; Wyhs, Nicolas; Yegnasubramanian, S; Lee, Peng; Melamed, Jonathan; Netto, George J.; Trock, Bruce; Demarzo, Angelo Michael; Sfanos, Karen.

In: Prostate, Vol. 74, No. 1, 01.2014, p. 61-69.

Research output: Contribution to journalArticle

@article{f967c3b49686402fb04e6199f5e94029,
title = "Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network",
abstract = "BACKGROUND The goal of the Prostate Cancer Biorepository Network (PCBN) is to develop a biorepository with high-quality, well-annotated specimens obtained in a systematic, reproducible fashion using optimized and standardized protocols, and an infrastructure to facilitate the growth of the resource and its wide usage by the prostate cancer research community. An emerging area of concern in the field of prostate cancer biobanking is an apparent shift in the proportion of surgical procedures performed for prostate cancer treatment from radical retropubic prostatectomy (RRP) to robot-assisted laparoscopic prostatectomy (RALP). Our study aimed to determine the potential impact of the RALP procedure on the detection of known prostate cancer biomarkers, and the subsequent suitability of RALP-derived specimens for prostate cancer biomarker studies. METHODS DNA and RNA were extracted from RRP and RALP specimens. Quality assessment was conducted using spectrophotometric analysis and RNA was analyzed for RNA integrity number (RIN) and by real-time reverse-transcription PCR (qRT-PCR) for racemase, hepsin, ERG, TMPRSS2-ERG gene fusions, and the microRNAs miR-26a, miR-26b, miR-141, and miR-221. RESULTS We demonstrate that extraction of derivatives from frozen tissues from RRP and RALP specimens yields samples of equally high quality as assessed by spectrophotometric and RIN analysis. Likewise, expression levels of genes analyzed by qRT-PCR did not differ between RRP and RALP-derived tissues. CONCLUSIONS Our studies indicate that samples obtained from RALP specimens may be suitable for prostate cancer biomarker studies - an important finding given the current shift in surgical procedures for prostate cancer treatment.",
keywords = "biobanking, biomarker, biorepository, DNA, prostate cancer, RNA",
author = "Medha Darshan and Qizhi Zheng and Fedor, {Helen L.} and Nicolas Wyhs and S Yegnasubramanian and Peng Lee and Jonathan Melamed and Netto, {George J.} and Bruce Trock and Demarzo, {Angelo Michael} and Karen Sfanos",
year = "2014",
month = "1",
doi = "10.1002/pros.22730",
language = "English (US)",
volume = "74",
pages = "61--69",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network

AU - Darshan, Medha

AU - Zheng, Qizhi

AU - Fedor, Helen L.

AU - Wyhs, Nicolas

AU - Yegnasubramanian, S

AU - Lee, Peng

AU - Melamed, Jonathan

AU - Netto, George J.

AU - Trock, Bruce

AU - Demarzo, Angelo Michael

AU - Sfanos, Karen

PY - 2014/1

Y1 - 2014/1

N2 - BACKGROUND The goal of the Prostate Cancer Biorepository Network (PCBN) is to develop a biorepository with high-quality, well-annotated specimens obtained in a systematic, reproducible fashion using optimized and standardized protocols, and an infrastructure to facilitate the growth of the resource and its wide usage by the prostate cancer research community. An emerging area of concern in the field of prostate cancer biobanking is an apparent shift in the proportion of surgical procedures performed for prostate cancer treatment from radical retropubic prostatectomy (RRP) to robot-assisted laparoscopic prostatectomy (RALP). Our study aimed to determine the potential impact of the RALP procedure on the detection of known prostate cancer biomarkers, and the subsequent suitability of RALP-derived specimens for prostate cancer biomarker studies. METHODS DNA and RNA were extracted from RRP and RALP specimens. Quality assessment was conducted using spectrophotometric analysis and RNA was analyzed for RNA integrity number (RIN) and by real-time reverse-transcription PCR (qRT-PCR) for racemase, hepsin, ERG, TMPRSS2-ERG gene fusions, and the microRNAs miR-26a, miR-26b, miR-141, and miR-221. RESULTS We demonstrate that extraction of derivatives from frozen tissues from RRP and RALP specimens yields samples of equally high quality as assessed by spectrophotometric and RIN analysis. Likewise, expression levels of genes analyzed by qRT-PCR did not differ between RRP and RALP-derived tissues. CONCLUSIONS Our studies indicate that samples obtained from RALP specimens may be suitable for prostate cancer biomarker studies - an important finding given the current shift in surgical procedures for prostate cancer treatment.

AB - BACKGROUND The goal of the Prostate Cancer Biorepository Network (PCBN) is to develop a biorepository with high-quality, well-annotated specimens obtained in a systematic, reproducible fashion using optimized and standardized protocols, and an infrastructure to facilitate the growth of the resource and its wide usage by the prostate cancer research community. An emerging area of concern in the field of prostate cancer biobanking is an apparent shift in the proportion of surgical procedures performed for prostate cancer treatment from radical retropubic prostatectomy (RRP) to robot-assisted laparoscopic prostatectomy (RALP). Our study aimed to determine the potential impact of the RALP procedure on the detection of known prostate cancer biomarkers, and the subsequent suitability of RALP-derived specimens for prostate cancer biomarker studies. METHODS DNA and RNA were extracted from RRP and RALP specimens. Quality assessment was conducted using spectrophotometric analysis and RNA was analyzed for RNA integrity number (RIN) and by real-time reverse-transcription PCR (qRT-PCR) for racemase, hepsin, ERG, TMPRSS2-ERG gene fusions, and the microRNAs miR-26a, miR-26b, miR-141, and miR-221. RESULTS We demonstrate that extraction of derivatives from frozen tissues from RRP and RALP specimens yields samples of equally high quality as assessed by spectrophotometric and RIN analysis. Likewise, expression levels of genes analyzed by qRT-PCR did not differ between RRP and RALP-derived tissues. CONCLUSIONS Our studies indicate that samples obtained from RALP specimens may be suitable for prostate cancer biomarker studies - an important finding given the current shift in surgical procedures for prostate cancer treatment.

KW - biobanking

KW - biomarker

KW - biorepository

KW - DNA

KW - prostate cancer

KW - RNA

UR - http://www.scopus.com/inward/record.url?scp=84890115054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890115054&partnerID=8YFLogxK

U2 - 10.1002/pros.22730

DO - 10.1002/pros.22730

M3 - Article

C2 - 24115205

AN - SCOPUS:84890115054

VL - 74

SP - 61

EP - 69

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 1

ER -